Analysts are heralding bepirovirsen as a potentially strong future growth driver for GSK and its infectious disease portfolio.
The survey was conducted by the Pistoia Alliance at the Clinical Trials Technology Congress (CTTC) in London.
Dr Imogen Kretzschmar, consultant psychiatrist at Mamedica, examines medical cannabis's mental health benefits for patients under specialist supervision.
The trial is expected to recruit around 100 healthy overweight or obese volunteers.
The CancerLinQ Suite uses AI to convert unstructured data into actionable insights and unifies quality governance.
Hansa will apply to the EMA to convert Idefrix’s conditional approval into full marketing authorisation.
